Unknown

Dataset Information

Pathway-guided monitoring of the disease course in bladder cancer with longitudinal urine proteomics.


ABSTRACT:

Background

Monitoring bladder cancer over time requires invasive and costly procedures. Less invasive approaches are required using readily available biological samples such as urine. In this study, we demonstrate a method for longitudinal analysis of the urine proteome to monitor the disease course in patients with bladder cancer.

Methods

We compared the urine proteomes of patients who experienced recurrence and/or progression (n = 13) with those who did not (n = 17). We identified differentially expressed proteins within various pathways related to the hallmarks of cancer. The variation of such pathways during the disease course was determined using our differential personal pathway index (dPPi) calculation, which could indicate disease progression and the need for medical

SUBMITTER: Carvalho LB 

PROVIDER: S-EPMC9842762 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature